NeoGenomics Inc vs Berkshire Hathaway Inc
A head-to-head of NeoGenomics Inc (NEO) and Berkshire Hathaway Inc (BRK-A) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | NEO | BRK-A |
|---|---|---|
| Market Cap | $1.17B | $1.03T |
| P/E (TTM) | — | 15.41 |
| Forward P/E | 222.22 | 21.10 |
| P/S | 1.61 | 2.78 |
| P/B | 0.28 | 1.44 |
| EV/EBITDA | -27.92 | 0.00 |
| Dividend Yield | — | — |
| Profit Margin | -13.30% | 18.01% |
| Gross Margin | 38.85% | 23.63% |
| Operating Margin | -9.09% | 16.03% |
| Revenue Growth (YoY) | +11.09% | -3.94% |
| FCF Yield | -0.43% | 2.43% |
| Debt / Equity | 41.83 | 19.38 |
| Current Ratio | 4.42 | 6.75 |
Share:
Compare NeoGenomics Inc with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.